Compare the effect of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics
Phase 1
- Conditions
- Diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT20170612034484N1
- Lead Sponsor
- Investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Being diabetic
Healthy liver enzymes
Age condition
Exclusion Criteria
Taking insulin
Age condition
Acute illness
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Before the intervention - ten days after the intervention - Twenty days after the intervention - thirty days after the intervention - the end of intervention. Method of measurement: Milligrams per deciliter.;Glycated hemoglobin. Timepoint: Before the intervention - the end of intervention. Method of measurement: Millimoles per mol.
- Secondary Outcome Measures
Name Time Method Alanine transaminase. Timepoint: Start - the twentieth day - end. Method of measurement: Unit per liter.;Aspartate transaminase. Timepoint: Start - the twentieth day - end. Method of measurement: Unit per liter.